RE:Short volume His original $12 price target was clearly too aggressive at the time but indicated he was angling for the lead on the eventual fundraising. His $3 current target is his "you did not give me the lead on either of the deals after I did my part to get it" price target. The company had only gotten better over the time he covered it (moving from HIV NASH to and FDA/EMA supported phase III general NASH program and making significant strides in fast-tracked cancer while sales of the legacy drugs moved marginally higher. The just has not been enough bad happening over that time to justify the massive price target reduction. Indeed, two rather incredible things happened in THTX's pipeline during that time.
scarlet1967 wrote: As per fintel 53k shares were shorted today which equals about 8% short volume.
So Mr. NASH managed to spook investors to sell almost 400k shares resulting in over 4% decline in SP so yes let’s feel sorry for him since he can’t pick up his next cheque from the company so he can book a holiday working on his tan, never mind his PT goes from $12 to $3 in less than 18 months based on what ever bogus analysis.